DarioHealth Corp (DRIO)

[Kev_Sh]

BGMS at elevated altitude study has been completed, however the user performance evaluation is still ongoing, does anyone know the reason of the delay, the study was suppose to be completed by end of Feb? I see that "Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials", does this have to with the delay? I hope they are close to wrapping this study.. As this will clear the gate for FDA approval.